1. Epidemiology of non-alcoholic fatty liver disease in North America;Arshad;Curr. Pharmaceut. Des.,2020
2. The Mexican consensus on nonalcoholic fatty liver disease;Bernal-Reyes;Rev. Gastroenterol. México,2019
3. Molecular mediators of hepatic steatosis and liver injury;Browning;JCL,2004
4. Pathogenesis and prevention of hepatic steatosis;Nassir;GastroHep,2015
5. Prevalencia de esteatosis hepática no alcohólica en pacientes diabéticos tipo 2, con o sin síndrome metabólico;Sanjinez Asbún;Rev. Méd. La Paz,2017